Business news – Page 32
-
Business
From philanthropy to sustainability
Corporate Social Responsibility in the pharmaceutical and chemical industries is changing
-
-
Business
Carbon Cycle’s gypsum purification process cleans up radioactive fertiliser waste
The patented process could prevent environmental damage and provide a new source of gypsum and rare-earth metals
-
Article
Pharma and healthcare meets data and digitalisation
UK-based company Life Science Integrates exists to facilitate collaboration between digital, pharma and life sciences industries – helping form partnerships that revolutionise healthcare
-
Article
Cultivating innovation in the UK’s life science industry
Scientific and digital collaboration is key to maintaining the UK’s esteemed status in global life sciences and pharma circles. CPI exists to facilitate and underpin those vital relationships
-
Article
Artificial intelligence: on the cusp of a digital revolution
AI is transforming the pharma industry and its drug discovery pipeline
-
Article
Ion mobility spectrometry: the future of pharma analysis
Ion mobility spectrometry is transforming the field of biomolecule research, with Waters technology at the forefront of this vital analytical innovation
-
Business
Reclaiming fuel from air
The companies trying to capture atmospheric carbon and transform it to hydrocarbons using green energy
-
-
Opinion
Will computers ever discover drugs from scratch?
With enough understanding and computing power, it should be possible, but will it happen?
-
Business
Former Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
Business
The rise of venture philanthropy
More and more charities are investing in companies, and looking for returns on that investment, as an alternative to traditional grants
-
Business
Nitrosamine contamination withdrawals spread to new drugs
After ranitidine recalls, EU regulators instruct companies to review all their products for potential impurities
-
Business
Sixth in a line of Alzheimer’s drugs fails in trials
Treatments designed to stop amyloid peptide formation all seem to cause cognitive impairment rather than prevent it
-
Article
The importance of solid form science in modern drug development
A recent study suggests that around 40% of drugs with market approval exhibit poor water solubility and although this is not a new problem, solutions like those offered by Johnson Matthey are still relevant to today’s pharma market
-
-
Business
Leaking filter caused deadly explosion at US plant
Blast that killed one and injured 30 others at a KMCO facility in Texas was caused by hole in pipe component
-
Opinion
Is bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
Business
Chemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided
-
Opinion
Embracing structural disorder
Medicinal chemists need to overcome their fear of fuzzy proteins